Newsletter | May 29, 2026

05.29.26 -- Sharing Clinical Trial Results With Participants Builds Trust

SPONSOR

Reduce start-up risk in precision oncology

In precision oncology, accelerating trial start-up and enrollment is critical to delivering timely impact for patients. By leveraging historical site performance data, sponsors can anticipate challenges early and reduce delays—creating a faster, more efficient path from screening to enrollment. 

Own your timeline.

CLINICAL DATA MANAGEMENT & ANALYTICS

It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust

CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.

Trailblazing Clinical Drug Development In Dermatology

AI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.

Managing Opportunities And Risks: Generative AI For Clinical Research

Explore how to bridge the gap between generative AI potential and clinical regulations through smarter oversight, adversarial agents, and a workforce prepared for human-AI collaboration.

An Integrated Approach To Biostatistics, Data, And Programming

By aligning biometrics expertise with advanced technologies and global regulatory standards, sponsors can optimize resources, ensure patient safety, and bring transformative therapies to market faster.

Real-Time Data Drives Analytical Efficiencies To Bring Drugs To Market

Real-time access to unified clinical data helps teams uncover safety signals and streamline collaboration. Learn how modern, AI‑powered workflows strengthen oversight and improve efficiency.

Rescue Studies

Clinical trials frequently encounter delays, and rescue studies have become vital to address this challenge, especially in complex therapeutic areas.

TRIAL MONITORING

QA Transitions Don't Create Inspection Risk — They Reveal It

Consultant Wijdan Suliman, MD, MHA, explains how QA leadership changes can reveal risks, including differences in the interpretation, lost historical context, and more.

How Modern Platforms Enable Connected Clinical Data Systems

Digital trials demand seamless data flow. APIs reduce manual work, improve oversight, and power flexible, connected study environments.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: